HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Toxicity, Transparency & Sunscreen Regs Among Top “Rose Sheet” Topics In 2011

This article was originally published in The Rose Sheet

Executive Summary

“The Rose Sheet” analyzes the stories that garnered the most reader interest and had the highest impact on the personal-care industry in 2011. The top topics include Johnson & Johnson’s reformulation of its baby-care products and the establishment of the Safe Cosmetics Alliance.

You may also be interested in...



Campaign For Safe Cosmetics To Keep Pushing For Product Reformulation In 2012

Activist group the Campaign for Safe Cosmetics says its top accomplishment in 2011 was getting Johnson & Johnson to reformulate its baby-care products. In 2012, the NGO plans to increase its pressure on firms to reformulate products, removing ingredients it deems unsafe.

New CEO Busiek Aims To Grow ICMAD’s Presence, Utility To Members

In an interview with “The Rose Sheet,” Pam Busiek – who was named CEO and president of the Independent Cosmetic Manufacturers and Distributors in July – discussed the trade association’s accomplishments for 2011 and priorities for next year.

IFRA Videos Designed To Educate, Feel Out Public On Ingredient Disclosure

The International Fragrance Association steps up its PR with a pair of videos designed to educate consumers about perfumery and the importance of preserving trade secrets.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel